Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.2B | 13.6B | 13.7B | 13.3B |
Cost of revenue | 8.1B | 8.6B | 8.6B | 8.2B |
Gross profit | — | 5.1B | 5.1B | 5.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 3.4B | 3.4B | 3.1B |
Operating income | — | 1.4B | 1.4B | 1.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 69.5M | 67.9M | 42.0M |
Other income expense | — | — | — | — |
Pretax income | — | 1.6B | 1.7B | 2.0B |
Tax provision | — | 390.4M | 421.8M | 546.6M |
Net income | — | 1.2B | 1.3B | 1.5B |
Basic EPS | — | 4.2 | 4.6 | 5.4 |
Diluted EPS | — | 4.2 | 4.5 | 5.3 |
Basic average shares | — | 278.4M | 277.8M | 277.6M |
Diluted average shares | — | 281.8M | 282.1M | 282.3M |
EBITDA | — | 1.8B | 2.0B | 2.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | 0 | 0 | 0 |